Loading clinical trials...
Loading clinical trials...
A Randomized, Open Label, Multicenter Study Comparing the Safety and Efficacy of Once Daily Regimen Containing Epzicom or Truvada Combined With Ritonavir Boosted Atazanavir as Initial Therapy for HIV-1 Infection (ET Study)
Conditions
Interventions
lamivudine, abacavir , ritonavir, atazanavir
emtricitabine, tenofovir, ritonavir, atazanavir
Locations
1
Japan
International Medical Center of Japan
Shinjuku, Tokyo, Japan
Start Date
October 1, 2007
Primary Completion Date
February 1, 2012
Completion Date
February 1, 2012
Last Updated
March 30, 2015
NCT06694805
NCT04142047
NCT07428330
NCT07225530
NCT06665646
NCT05897099
Lead Sponsor
International Medical Center of Japan
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions